Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
Clinical trial NCT07254858 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07254858
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-12-30
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.